Publications by authors named "Daniel Brookings"

Claim this Profile
C
Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
Alexander Vugler, James O'connell, Mai Anh Nguyen, Dietmar Weitz, Thomas Leeuw, Daniel Brookings

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
Alexander Vugler, James O'Connell, Mai Anh Nguyen, Dietmar Weitz, Thomas Leeuw, Daniel Brookings

Front Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.
James Reuberson, Helen Horsley, Richard J Franklin, Daniel Ford, Judi Neuss, Daniel Brookings

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K.
Rodger A Allen, Daniel C Brookings, Mark J Powell, Jean Delgado, Lindsay K Shuttleworth

J Pharmacol Exp Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.
Gill Holdsworth, Patrick Slocombe, Carl Doyle, Bernadette Sweeney, Vaclav Veverka, Daniel Brookings

J Biol Chem· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting.
Christoph Meier, Daniel C Brookings, Thomas A Ceska, Carl Doyle, Haiping Gong

J Struct Biol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused thiophene derivatives as MEK inhibitors.
Victoria E Laing, Daniel C Brookings, Rachel J Carbery, Jose Gascon Simorte, Martin C Hutchings

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase.
Rikki Alexander, Ahrani Balasundaram, Mark Batchelor, Daniel Brookings, Karen Crépy

Bioorg Med Chem Lett· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel nucleotide triphosphates as potent P2Y2 agonists.
Daniel Brookings, Richard J Davenport, Jeremy Davis, Frances C A Galvin, Steve Lloyd

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide deformylase inhibitors with activity against respiratory tract pathogens.
Stephen P East, R Paul Beckett, Daniel C Brookings, John M Clements, Sheila Doel

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis